The Valley Desk

ArticlePharmaceutical statisticsPublished

PKBOIN-12: A Bayesian Optimal Interval Phase I/II Design Incorporating Pharmacokinetics Outcomes to Find the Optimal Biological Dose

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

Publication record

Type
Article
Venue
Pharmaceutical statistics
Published
Subject terms
Humans; Bayes Theorem; Maximum Tolerated Dose; Pharmacokinetics; Dose-Response Relationship, Drug; Algorithms; Research Design; Computer Simulation; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Optimal Biological Dose; Bayesian Optimal Interval Design
PubMed ID
39448544
Added to directory
Source checked

Report a correction or request removal